Skip to content

Clinical trials

Phase 3 Gastrointestinal Hemorrhage trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Hemorrhage Phase: Phase 3 Country / region: Canada Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University2
Cogentus Pharmaceuticals1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Ottawa Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Hemorrhage5
Acute Coronary Syndrome1
Cerebrovascular Disorders1
Coronary Artery Disease1
Coronary Thrombosis1
Duodenal Obstruction1
Duodenal Ulcer1
Dyspepsia1
Esophagitis, Peptic1
Gastric Outlet Obstruction1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.